Speaker(s):
Vimal Bodiwala, MD, Staff Member, Geisinger - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
- 1) Describe the management of acute severe ulcerative colitis.
- 2) Recognize the importance of pharmacologic prophylaxis against thromboembolism.
- 3) Appreciate the importance of multidisciplinary care in taking care of hospitalized patients with IBD flares.
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Stefanie Leader, DO, Stanley Martin, MD, Dan Dometita, DO, Malachi Courtney, MD, Eric Hossler, DO, Stacey Coolbaugh, RDN, and Donald Weider, PA-C have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPAA compliant.
Commercial Support for this Session
None
Session date:
02/07/2025 - 12:00pm to 1:00pm EST
Location:
Virtual via Microsoft Teams & Henry Hood Auditorium
Danville, PA
17822
United States
See map: Google Maps
Add to calendar:
- 1.00 AAPA Category I CME
- 1.00 AMA PRA Category 1 Credit™
- 1.00 CDR
- 1.00 Participation Credit